Confident Investing Starts With TipRanks Premium

Go Ultimate 55% OFF

CASI Stock Latest News

The FlyEight new option listings and two option delistings on February 27th8M agoASM CASI

Company AnnouncementsCASI Pharmaceuticals to Be Delisted From Nasdaq, Shares Expected to Move to OTC Market8M ago6K CASI
The FlyCasi Pharmaceuticals receives delisting decision from Nasdaq8M agoCASI
The FlyCasi Pharmaceuticals receives delisting decision from Nasdaq8M agoCASI
Company AnnouncementsCASI Pharmaceuticals Closes Third Tranche of US$20 Million Convertible Note Financing8M ago6K CASI

CASI Pharmaceuticals Names New Executive Chairman, Streamlines U.S. Operations Amid Listing Pressure

Company AnnouncementsCASI Pharmaceuticals Names New Executive Chairman, Streamlines U.S. Operations Amid Listing Pressure8M ago6K CASI

Company AnnouncementsCASI Pharmaceuticals Secures China Drug Registration for Thiotepa Ahead of Planned Asset Disposal8M ago6K CASI

Company AnnouncementsCASI Pharmaceuticals Fails to Renew FOLOTYN Import License in China, Halts Sales9M ago6K CASI

The FlyCasi Pharmaceuticals announces NMPA approval of CTA for Phase 1/2 CID-103 study9M agoCASI
Company AnnouncementsCASI Pharmaceuticals Closes Second Tranche of US$20 Million Convertible Note Financing9M ago6K CASI
The FlyCasi Pharmaceuticals announces results from Phase 1 study of CID-1039M agoCASI
Company AnnouncementsCASI Pharmaceuticals Closes First US$5 Million Tranche of Convertible Note Financing10M ago6K CASI

CASI Pharmaceuticals Wins Nasdaq Listing Extension to February 2026

Company AnnouncementsCASI Pharmaceuticals Wins Nasdaq Listing Extension to February 202610M ago6K CASI

Company AnnouncementsCASI Pharmaceuticals Secures $20 Million for Renal AMR Study10M ago6K CASI

The FlyCasi Pharmaceuticals enters into $20M convertible note financing10M agoCASI

RatingsBuy Rating for CASI Pharmaceuticals: Promising CID-103 Clinical Data and Competitive Positioning10M agoCASI
The FlyCasi Pharmaceuticals announces CID-103 immune thrombocytopenia study results11M agoCASI
Company AnnouncementsCASI Pharmaceuticals Appoints James Huang as Non-Executive Chairman11M ago6K CASI
The FlyCasi Pharmaceuticals appoints James Huang as non-executive chairman11M agoCASI

CASI Pharmaceuticals Reports Q3 2025 Results Amid Nasdaq Delisting Appeal

Company AnnouncementsCASI Pharmaceuticals Reports Q3 2025 Results Amid Nasdaq Delisting Appeal11M ago6K CASI

Company AnnouncementsCASI Pharmaceuticals Appeals Nasdaq Delisting Determination11M ago6K CASI

Pre-EarningsCASI Earnings Report this Week: Is It a Buy, Ahead of Earnings?11M agoCASI